Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | carbon catabolite repressor protein, putative | 0.0009 | 0.0053 | 0.0199 |
Trichomonas vaginalis | carbon catabolite repressor protein, putative | 0.0009 | 0.0053 | 0.0199 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0043 | 0.2667 | 1 |
Brugia malayi | CXXC zinc finger family protein | 0.0065 | 0.4393 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0015 | 0.0525 | 0.1969 |
Trichomonas vaginalis | Phospholipase C precursor, putative | 0.0009 | 0.0053 | 0.0199 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0043 | 0.2667 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0015 | 0.0525 | 0.1969 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.002 | 0.092 | 0.1996 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0043 | 0.2667 | 0.5651 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0043 | 0.2667 | 1 |
Echinococcus granulosus | mixed lineage leukemia protein mll | 0.0016 | 0.0634 | 0.1257 |
Schistosoma mansoni | cpg binding protein | 0.0069 | 0.4678 | 0.465 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0043 | 0.2667 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0525 | 0.1969 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0015 | 0.0525 | 0.1969 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0525 | 0.1969 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0043 | 0.2667 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0525 | 0.1969 |
Echinococcus multilocularis | mixed lineage leukemia protein mll | 0.0016 | 0.0634 | 0.1257 |
Loa Loa (eye worm) | histone methyltransferase | 0.002 | 0.0939 | 0.2042 |
Schistosoma mansoni | cpg binding protein | 0.0069 | 0.4678 | 0.465 |
Trichomonas vaginalis | skeletal muscle/kidney enriched inositol 5-phosphatase, putative | 0.0009 | 0.0053 | 0.0199 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0016 | 0.0634 | 0.1257 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0043 | 0.2667 | 1 |
Echinococcus granulosus | cpg binding protein | 0.0069 | 0.4678 | 1 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0043 | 0.2667 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0016 | 0.0634 | 0.1257 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.002 | 0.0939 | 0.1916 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0015 | 0.0525 | 0.1969 |
Trichomonas vaginalis | type II inositol 5-phosphatase, putative | 0.0009 | 0.0053 | 0.0199 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0525 | 0.1969 |
Toxoplasma gondii | exonuclease III APE | 0.0043 | 0.2667 | 0.2966 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0043 | 0.2667 | 1 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0015 | 0.0525 | 0.1969 |
Trichomonas vaginalis | ocrl type II inositol 5-phosphatase, putative | 0.0009 | 0.0053 | 0.0199 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0043 | 0.2667 | 1 |
Trichomonas vaginalis | helicase, putative | 0.0015 | 0.0525 | 0.1969 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0043 | 0.2667 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0525 | 0.1969 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0016 | 0.0634 | 0.0584 |
Trichomonas vaginalis | type IV inositol 5-phosphatase, putative | 0.0009 | 0.0053 | 0.0199 |
Onchocerca volvulus | 0.0065 | 0.4393 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0525 | 0.1969 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0124 | 0.8867 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0043 | 0.2667 | 1 |
Trichomonas vaginalis | sphingomyelinase C 2 precursor, putative | 0.0009 | 0.0053 | 0.0199 |
Schistosoma mansoni | cpg binding protein | 0.0065 | 0.4393 | 0.4363 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0015 | 0.0525 | 0.1969 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.002 | 0.0939 | 0.1916 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0043 | 0.2667 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0043 | 0.2667 | 0.2628 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0043 | 0.2667 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.0109 | 0.0056 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0015 | 0.0525 | 0.1969 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0525 | 0.1969 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0525 | 0.1969 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0065 | 0.4393 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0525 | 0.1969 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0043 | 0.2667 | 0.6023 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0015 | 0.0525 | 0.1969 |
Trichomonas vaginalis | carbon catabolite repressor protein, putative | 0.0009 | 0.0053 | 0.0199 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0043 | 0.2667 | 0.5651 |
Schistosoma mansoni | ap endonuclease | 0.0043 | 0.2667 | 0.2628 |
Echinococcus multilocularis | cpg binding protein | 0.0069 | 0.4678 | 1 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0043 | 0.2667 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0043 | 0.2667 | 0.6023 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
LD10 (ADMET) | = 110 mg kg-1 | Toxicity in ip dosed C3H/DBA2F1 hybrid mouse allografted with mouse L1210 cells administered for 5 days measured up to 8 days | ChEMBL. | 660586 |
LD10 (ADMET) | = 110 mg kg-1 | Toxicity in mouse L1210 cells xenografted mouse assessed as compound proving lethal to 10% animal | ChEMBL. | 536990 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.